Literature DB >> 15146089

Causes of erectile dysfunction.

Jeremy P W Heaton1, Michael A Adams.   

Abstract

Erectile dysfunction (ED) arises as a result of a collision of circumstances among any of a number of factors (e.g., risk factors, causes, probable associations), each with its own primary power to affect the outcome. Furthermore, each of the components has its own timing as part of a complex effort of compensation and adjustment that often obscures the individual details. In the end, ED results from a failure of local tissues or systemic supply and control structures. The power of any individual "cause" to degrade erectile function is an important but as-yet unquantified property. The power of a small abnormality over a long or critical period (e.g., organogenesis), or many small contributions, or multiple risk factors will certainly be greater than the sum of the individual elements. Without a full quantitation of pathways and their potential influence, one can compare the importance of causative factors only in limited ways. Not surprisingly, it is the presence of a multiplicity of unidentified or poorly understood causative factors that accounts in large measure for the current inability to cure and prevent ED. There are two other important properties of a putatively causative factor for ED--reversibility and preventability--and these are strongly influenced by the time of onset and the duration of impact. Thus, a critical understanding that comes from recognizing the importance of the temporal associations of component factors is that the causes of ED in an individual may be guessed at but cannot be fully disclosed by an analysis of a "snapshot" of the disease taken at the time of diagnosis. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15146089     DOI: 10.1385/ENDO:23:2-3:119

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  47 in total

Review 1.  Cigarette smoking and erectile dysfunction.

Authors:  J Y Jeremy; D P Mikhailidis
Journal:  J R Soc Promot Health       Date:  1998-06

Review 2.  The dual control model of male sexual response: a theoretical approach to centrally mediated erectile dysfunction.

Authors:  J Bancroft; E Janssen
Journal:  Neurosci Biobehav Rev       Date:  2000-07       Impact factor: 8.989

3.  Erectile function and nocturnal penile tumescence in patients with prostate cancer undergoing luteinizing hormone-releasing hormone agonist therapy.

Authors:  K Marumo; S Baba; M Murai
Journal:  Int J Urol       Date:  1999-01       Impact factor: 3.369

Review 4.  Nitric oxide regulation of penile erection: biology and therapeutic implications.

Authors:  Arthur L Burnett
Journal:  J Androl       Date:  2002 Sep-Oct

Review 5.  Circulatory control and the supercontrollers.

Authors:  P I Korner
Journal:  J Hypertens       Date:  1995-12       Impact factor: 4.844

6.  Aortofemoral surgery and sexual function.

Authors:  L Cormio; J Edgren; M Lepäntalo; O Lindfors; H Nisén; O Saarinen; M Ruutu
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-05       Impact factor: 7.069

Review 7.  Phosphodiesterase inhibitors for the treatment of erectile dysfunction.

Authors:  Andrea Küthe; Francesco Montorsi; Karl-Erik Andersson; Christian G Stief
Journal:  Curr Opin Investig Drugs       Date:  2002-10

8.  Vasoconstrictors in erectile physiology.

Authors:  T M Mills; K Chitaley; R W Lewis
Journal:  Int J Impot Res       Date:  2001-12       Impact factor: 2.896

Review 9.  Initial lesions of vascular aging disease (arteriosclerosis).

Authors:  J Kunz
Journal:  Gerontology       Date:  2000 Nov-Dec       Impact factor: 5.140

Review 10.  Sexual dysfunction and depression: etiology, prevalence, and treatment.

Authors:  R Shabsigh; L Zakaria; A G Anastasiadis; A S Seidman
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 2.862

View more
  5 in total

Review 1.  Risk factors of erectile dysfunction among diabetes patients in Africa: A systematic review and meta-analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Pammla Margaret Petrucka; Habtamu Abera Areri; Yared Asmare Aynalem
Journal:  J Clin Transl Endocrinol       Date:  2020-07-03

2.  Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

Authors:  Christopher J Wingard; Fatiha Moukdar; Raju Y Prasad; Brook L Cathey; Lois Wilkinson
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

3.  COMP-angiopoietin-1 promotes cavernous angiogenesis in a type 2 diabetic rat model.

Authors:  Sun-Ouck Kim; Hyun-Suk Lee; Kyuyoun Ahn; Kwangsung Park
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

Review 4.  Prevalence of Erectile Dysfunction in Patients with Diabetes Mellitus and Its Association with Body Mass Index and Glycated Hemoglobin in Africa: A Systematic Review and Meta-Analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Yared Asmare Aynalem
Journal:  Int J Endocrinol       Date:  2020-01-18       Impact factor: 3.257

5.  Association between Nocturnal Frequency and Erectile Function in Eugonadal Men with Benign Prostatic Obstruction: A Cross Sectional Study.

Authors:  Dong Sup Lee; Sae Woong Kim; Dong Wan Sohn
Journal:  World J Mens Health       Date:  2020-01-29       Impact factor: 5.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.